Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Metabolomics in epidemiology: sources of variability in metabolite measurements and implications.

Sampson JN, Boca SM, Shu XO, Stolzenberg-Solomon RZ, Matthews CE, Hsing AW, Tan YT, Ji BT, Chow WH, Cai Q, Liu DK, Yang G, Xiang YB, Zheng W, Sinha R, Cross AJ, Moore SC.

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):631-40. doi: 10.1158/1055-9965.EPI-12-1109. Epub 2013 Feb 8.

2.

Sources of variability in metabolite measurements from urinary samples.

Xiao Q, Moore SC, Boca SM, Matthews CE, Rothman N, Stolzenberg-Solomon RZ, Sinha R, Cross AJ, Sampson JN.

PLoS One. 2014 May 1;9(5):e95749. doi: 10.1371/journal.pone.0095749. eCollection 2014.

3.

Metabolomics in nutritional epidemiology: identifying metabolites associated with diet and quantifying their potential to uncover diet-disease relations in populations.

Guertin KA, Moore SC, Sampson JN, Huang WY, Xiao Q, Stolzenberg-Solomon RZ, Sinha R, Cross AJ.

Am J Clin Nutr. 2014 Jul;100(1):208-17. doi: 10.3945/ajcn.113.078758. Epub 2014 Apr 16.

4.

A prospective study of serum metabolites and colorectal cancer risk.

Cross AJ, Moore SC, Boca S, Huang WY, Xiong X, Stolzenberg-Solomon R, Sinha R, Sampson JN.

Cancer. 2014 Oct 1;120(19):3049-57. doi: 10.1002/cncr.28799. Epub 2014 Jun 3.

5.
6.

Development of a universal metabolome-standard method for long-term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery.

Peng J, Chen YT, Chen CL, Li L.

Anal Chem. 2014 Jul 1;86(13):6540-7. doi: 10.1021/ac5011684. Epub 2014 Jun 10.

PMID:
24877652
7.

Targeted metabolomics identifies reliable and stable metabolites in human serum and plasma samples.

Breier M, Wahl S, Prehn C, Fugmann M, Ferrari U, Weise M, Banning F, Seissler J, Grallert H, Adamski J, Lechner A.

PLoS One. 2014 Feb 24;9(2):e89728. doi: 10.1371/journal.pone.0089728. eCollection 2014.

8.

Reproducibility of metabolomic profiles among men and women in 2 large cohort studies.

Townsend MK, Clish CB, Kraft P, Wu C, Souza AL, Deik AA, Tworoger SS, Wolpin BM.

Clin Chem. 2013 Nov;59(11):1657-67. doi: 10.1373/clinchem.2012.199133. Epub 2013 Jul 29.

9.

Development of isotope labeling liquid chromatography mass spectrometry for mouse urine metabolomics: quantitative metabolomic study of transgenic mice related to Alzheimer's disease.

Peng J, Guo K, Xia J, Zhou J, Yang J, Westaway D, Wishart DS, Li L.

J Proteome Res. 2014 Oct 3;13(10):4457-69. doi: 10.1021/pr500828v. Epub 2014 Sep 15.

PMID:
25164377
10.

Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry.

Hsing AW, Stanczyk FZ, Bélanger A, Schroeder P, Chang L, Falk RT, Fears TR.

Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):1004-8.

11.

Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study.

Struck-Lewicka W, Kordalewska M, Bujak R, Yumba Mpanga A, Markuszewski M, Jacyna J, Matuszewski M, Kaliszan R, Markuszewski MJ.

J Pharm Biomed Anal. 2015;111:351-61. doi: 10.1016/j.jpba.2014.12.026. Epub 2015 Jan 6.

PMID:
25684700
12.

Exploratory investigation of plasma metabolomics in human lung adenocarcinoma.

Wen T, Gao L, Wen Z, Wu C, Tan CS, Toh WZ, Ong CN.

Mol Biosyst. 2013 Sep;9(9):2370-8. doi: 10.1039/c3mb70138g.

PMID:
23857124
13.

Absolute quantification of choline-related biomarkers in breast cancer biopsies by liquid chromatography electrospray ionization mass spectrometry.

Mimmi MC, Finato N, Pizzolato G, Beltrami CA, Fogolari F, Corazza A, Esposito G.

Anal Cell Pathol (Amst). 2013;36(3-4):71-83. doi: 10.3233/ACP-130082.

14.

LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort.

Xiao JF, Varghese RS, Zhou B, Nezami Ranjbar MR, Zhao Y, Tsai TH, Di Poto C, Wang J, Goerlitz D, Luo Y, Cheema AK, Sarhan N, Soliman H, Tadesse MG, Ziada DH, Ressom HW.

J Proteome Res. 2012 Dec 7;11(12):5914-23. doi: 10.1021/pr300673x. Epub 2012 Nov 1.

15.

Identification of human plasma metabolites exhibiting time-of-day variation using an untargeted liquid chromatography-mass spectrometry metabolomic approach.

Ang JE, Revell V, Mann A, Mäntele S, Otway DT, Johnston JD, Thumser AE, Skene DJ, Raynaud F.

Chronobiol Int. 2012 Aug;29(7):868-81. doi: 10.3109/07420528.2012.699122.

16.

Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.

Liang Q, Wang C, Li B.

Appl Biochem Biotechnol. 2015 Aug;176(8):2170-84. doi: 10.1007/s12010-015-1706-z. Epub 2015 Jun 19.

PMID:
26088916
17.

Quantitative proteomics and metabolomics analysis of normal human cerebrospinal fluid samples.

Stoop MP, Coulier L, Rosenling T, Shi S, Smolinska AM, Buydens L, Ampt K, Stingl C, Dane A, Muilwijk B, Luitwieler RL, Sillevis Smitt PA, Hintzen RQ, Bischoff R, Wijmenga SS, Hankemeier T, van Gool AJ, Luider TM.

Mol Cell Proteomics. 2010 Sep;9(9):2063-75. doi: 10.1074/mcp.M900877-MCP200.

18.

The Role of Metabolomics in the Study of Cancer Biomarkers and in the Development of Diagnostic Tools.

Trezzi JP, Vlassis N, Hiller K.

Adv Exp Med Biol. 2015;867:41-57. doi: 10.1007/978-94-017-7215-0_4. Review.

PMID:
26530359
19.

Impact of Pre-analytic Blood Sample Collection Factors on Metabolomics.

Townsend MK, Bao Y, Poole EM, Bertrand KA, Kraft P, Wolpin BM, Clish CB, Tworoger SS.

Cancer Epidemiol Biomarkers Prev. 2016 May;25(5):823-9. doi: 10.1158/1055-9965.EPI-15-1206. Epub 2016 Mar 3.

PMID:
26941367
20.

Characterization of intrinsic variability in time-series metabolomic data of cultured mammalian cells.

Le H, Jerums M, Goudar CT.

Biotechnol Bioeng. 2015 Nov;112(11):2276-83. doi: 10.1002/bit.25646. Epub 2015 Sep 17.

PMID:
25976859
Items per page

Supplemental Content

Write to the Help Desk